These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1627980)

  • 1. Neuroleptic malignant syndrome and preexisting brain damage.
    Lazarus A
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):185-7. PubMed ID: 1627980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case study: neuroleptic malignant syndrome without pyrexia.
    Hynes AF; Vickar EL
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fulminant case of neuroleptic malignant syndrome.
    Teo SK; Lam KN; Chew WL
    Singapore Med J; 1994 Feb; 35(1):110-1. PubMed ID: 8009269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
    Bellamy CJ; Kane-Gill SL; Falcione BA; Seybert AL
    J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
    Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y
    J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
    Hermesh H; Huberman M; Radvan H; Kott E
    J Nerv Ment Dis; 1984 Nov; 172(11):692-5. PubMed ID: 6238132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
    Kimura T; Yoshida H
    No To Shinkei; 1994 Sep; 46(9):859-62. PubMed ID: 7999444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
    Bambrick M; Wilson D
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():377-81. PubMed ID: 1356040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance.
    Morita T; Shishido H; Tei Y; Inoue S; Nagayama K
    J Palliat Med; 2004 Dec; 7(6):861-4. PubMed ID: 15684854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J; Jakob J; Bender HJ; Hewer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome.
    Kornhuber J; Weller M
    Curr Opin Neurol; 1994 Aug; 7(4):353-7. PubMed ID: 7952245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.
    Woodbury MM; Woodbury MA
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1161-4. PubMed ID: 1429421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of malignant neuroleptic syndrome. Case report].
    Martius P; Hüther R; Zilker T
    Nervenarzt; 1996 May; 67(5):418-21. PubMed ID: 9005355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.